Plain-English translation of NCT06101277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding locally ablative therapies—special targeted treatments that use radiation or heat to destroy tumors—alongside your current cancer medications can help keep your cancer under control. The study focuses on people whose cancer is spreading despite being on systemic therapy (medications taken throughout the body). Researchers want to see if combining both approaches works better than medication alone.
When cancers start spreading to new areas despite treatment, doctors often have limited options. This trial explores whether targeting just the new or worsening tumors with focused radiation or heat—while continuing your current medications—could help extend the time your cancer stays stable and delay the need to switch to different drugs.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will continue taking your current cancer medications while also receiving either stereotactic ablative radiotherapy (focused radiation) or interventional radiology ablation (heat-based treatment) to target your new or worsening tumors—whichever your doctor determines is safest for you. Your medical team will monitor your response at three months and continue following your health for up to five years after the ablative treatment to see how long your cancer stays stable.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States